ENAapplication/xmlftp://ftp.sra.ebi.ac.uk/vol1/fastq/ERR123/023/ERR12312123/ERR12312123.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/ERR123/017/ERR12312117/ERR12312117.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/ERR123/012/ERR12312112/ERR12312112.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/ERR123/021/ERR12312121/ERR12312121.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/ERR123/015/ERR12312115/ERR12312115.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/ERR123/019/ERR12312119/ERR12312119.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/ERR123/010/ERR12312110/ERR12312110.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/ERR123/026/ERR12312126/ERR12312126.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/ERR123/027/ERR12312127/ERR12312127.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/ERR123/013/ERR12312113/ERR12312113.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/ERR123/024/ERR12312124/ERR12312124.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/ERR123/011/ERR12312111/ERR12312111.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/ERR123/025/ERR12312125/ERR12312125.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/ERR123/018/ERR12312118/ERR12312118.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/ERR123/014/ERR12312114/ERR12312114.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/ERR123/022/ERR12312122/ERR12312122.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/ERR123/020/ERR12312120/ERR12312120.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/ERR123/016/ERR12312116/ERR12312116.fastq.gzprimaryOK200GenomicsUCPHUNIVERSITY OF COPENHAGENhttps://www.ebi.ac.uk/ena/browser/view/PRJEB70315In this project, a high-throughput screening was performed on three saturated Tn5 mutant libraries constructed in aminoglycoside resistant E. coli MG1655 utilizing a transposon-directed insertion site sequencing (TraDIS) approach. The aim of this study was to identify conditionally essential genes in aminoglycoside resistant E. coli during exposure with streptomycin, gentamicin and neomycin.xref:EuropePMC:PMC10879529ENAAlkalescens-Dispar Group, antibiotic, Therapy, Bacterium coli, Materials, determination, antibiotique, antimicrobials, Compounds, Gene, bacterium E3, antimicrobial agents, EAggEC, Antibacterial Agent, Cistrons, Enteroaggregative E. coli, Anti Mycobacterial Agents, Agent, disease management., microbicides, Diffusely Adherent E. coli, Bacillus coli, Anti Mycobacterial Agent, Escherchia coli, chemical analysis, Genetic Materials, Antibiotic, microbicide, Bacteriocidal, Enteroinvasive Escherichia coli, Aminoglycoside, Enterococcus coli, Bacteriocidal Agents, Bacteriocide, Anti Bacterial Agent, Bacteriocides, Genetic Material, Anti-Mycobacterial Agent, Antimycobacterial, antibiotics, antimicrobial, treatment, Antimycobacterial Agents, Diffusely Adherent Escherichia coli, Anti Bacterial Agents, Genetic, Escherichia/Shigella coli, Enteroinvasive E. coli, Genomes, Antibacterial, Antibiotika, Anti Bacterial Compounds, Anti Bacterial Compound, E coli, whole genome, Anti-Mycobacterial, Treatments, E. coli, Anti-Bacterial Compounds, Bacteriocidal Agent, Antibacterial Agents, Fitness and Exercise, Eschericia coli, Enteroaggregative Escherichia coli, Anti-Bacterial Agent, Anti-Bacterial, Bacterium coli commune, Agents, Anti-Mycobacterial Agents, Therapeutic, Material, Compound, Therapies, Antimycobacterial Agent, Cistron, Treatment, Antibiotics, assay, Anti-Bacterial Compound, AntibiotikumBacterium coli, Aminoglycoside, Enterococcus coli, Escherichia/Shigella coli, Bacterium coli commune, Bacillus coli, E. coli.falseTraDIS in aminoglycoside-resistant E. coli MG1655Genome-wide analysis of fitness-genes in aminoglycoside-resistant Escherichia coli during antibiotic treatment2024-03-312024-03-31PRJEB70315